Orgenesis Inc.
ORGS · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $347 | $246 | $141 | -$13,599 |
| % Growth | 41.1% | 74.5% | 101% | – |
| Cost of Goods Sold | $585 | $995 | $758 | $3,169 |
| Gross Profit | -$238 | -$749 | -$617 | -$16,768 |
| % Margin | -68.6% | -304.5% | -437.6% | 123.3% |
| R&D Expenses | $4,337 | $1,318 | $2,267 | $43 |
| G&A Expenses | $2,314 | $1,780 | $2,821 | $26,460 |
| SG&A Expenses | $2,314 | $2,001 | $5,996 | $26,460 |
| Sales & Mktg Exp. | $0 | $281 | $3,175 | $0 |
| Other Operating Expenses | $1,505 | $0 | $0 | $28,651 |
| Operating Expenses | $8,156 | $3,319 | $8,263 | $55,154 |
| Operating Income | -$8,394 | -$4,068 | -$8,880 | -$71,922 |
| % Margin | -2,419% | -1,653.7% | -6,297.9% | 528.9% |
| Other Income/Exp. Net | $17,628 | -$5,293 | -$1,059 | $27,438 |
| Pre-Tax Income | $9,234 | -$9,361 | -$9,989 | -$44,484 |
| Tax Expense | $114 | $5 | $16 | -$141 |
| Net Income | $9,120 | -$8,904 | -$9,765 | -$34,392 |
| % Margin | 2,628.2% | -3,619.5% | -6,925.5% | 252.9% |
| EPS | -0.19 | -0.23 | -0.29 | -2.09 |
| % Growth | 17.4% | 20.7% | 86.1% | – |
| EPS Diluted | -0.19 | -0.23 | -0.29 | -2.09 |
| Weighted Avg Shares Out | 47,152 | 38,861 | 33,177 | 3,167 |
| Weighted Avg Shares Out Dil | 47,152 | 38,861 | 33,177 | 3,167 |
| Supplemental Information | – | – | – | – |
| Interest Income | $15 | $20 | $0 | $0 |
| Interest Expense | $1,033 | $639 | $802 | $538 |
| Depreciation & Amortization | $538 | $706 | $381 | $194 |
| EBITDA | -$7,663 | -$8,016 | -$8,806 | -$43,752 |
| % Margin | -2,208.4% | -3,258.5% | -6,245.4% | 321.7% |